Adam Aukland-Peck is an associate in the Litigation Department.
Mr. Aukland-Peck joined Debevoise in 2017. In 2020 he clerked for the Hon. Mary Kay Vyskocil ...
Read Full Biography
Publications
-
Increased FCA Enforcement Targeting PE Firms Expected in 2024
11 March 2024
Helen V. Cantwell
, Courtney M. Dankworth
, Mark P. Goodman
, Maura Kathleen Monaghan
, Winston M. Paes
, Shannon Rose Selden
, Jacob W. Stahl
, Adam Aukland-Peck
, Kaitlyn McGill
-
Court Finds That Delaware Law Does Not Preclude Derivative Standing in Bankruptcy but Reaffirms Validity of Exculpation Provisions
6 March 2024
M. Natasha Labovitz
, Shannon Rose Selden
, Erica S. Weisgerber
, Zachary H. Saltzman
, Elie J. Worenklein
, Adam Aukland-Peck
-
Private Equity Report: 2024 Outlook
February 2024
Christopher Anthony
, Katherine Ashton
, Andrew L. Bab
, Paul S. Bird
, Dominic Blaxill
, Ezra Borut
, Geoffrey P. Burgess
, Andrew J. Ceresney
, Charu A. Chandrasekhar
, Jennifer L. Chu
, Luke Dembosky
, E. Drew Dutton
, Jane Engelhardt
, Avi Gesser
, Andrew J. Gershon
, Nia I. Goodman
, David Grosgold
, Jyotin Hamid
, Ted Hassi
, Morgan J. Hayes
, Peter J. Irwin
, Eric T. Juergens
, Robert B. Kaplan
, M. Natasha Labovitz
, Jonathan F. Lewis
, Sidney P. Levinson
, Andrew M. Levine
, Erez Liebermann
, Timothy McIver
, Maura Kathleen Monaghan
, Edwin Northover
, Brett M. Novick
, Marc Ponchione
, Ryan T. Rafferty
, Natalie L. Reid
, Julie M. Riewe
, Kevin Rinker
, Samantha J. Rowe
, Paul D. Rubin
, Michael Schaper
, Kevin M. Schmidt
, Scott B. Selinger
, Aly Love (f/k/a Simons)
, Thomas Smith
, Kristin A. Snyder
, Steven J. Slutzky
, Ramya S. Tiller
, Patricia Volhard
, Erica S. Weisgerber
, Kyra K. Bromley
, Alison E. Buckley-Serfass
, Jennifer R. Cestaro
, Stuart Hammer
, Jin-Hyuk Jang
, Wen-Wei Lai
, Michael P. McGuigan
, Sheena Paul
, Melissa Runsten
, Tricia Bozyk Sherno
, Ulysses Smith
, Sergio Torres
, Elie J. Worenklein
, Adam Aukland-Peck
, Josephine Chen
, Perpétua B. Chéry
, Paul Eastham
, Isabelle Glimcher
, Yiran Ji
, Maryam Kanna
, Leah Martin
, Sophie Michalski
, Diana Moise
, David J. Swiedler
, Perri M. Weinstein
, Nathan R. Hogan
-
Chevron Under Fire: What Healthcare and Life Sciences Investors Should Know
19 January 2024
Andrew L. Bab
, Jennifer L. Chu
, Mark P. Goodman
, Maura Kathleen Monaghan
, Kevin Rinker
, Paul D. Rubin
, Melissa Runsten
, Jacob W. Stahl
, Adam Aukland-Peck
, Zoe Jacoby
, Adriana Kranjac
, Kaitlyn McGill
-
Top 10 Healthcare and Life Sciences Issues to Watch in 2024
4 January 2024
Andrew L. Bab
, Jennifer L. Chu
, Mark P. Goodman
, Ted Hassi
, Maura Kathleen Monaghan
, Kevin Rinker
, Paul D. Rubin
, Michael Schaper
, Erica S. Weisgerber
, Kim T. Le
, Melissa Runsten
, Jacob W. Stahl
, Adam Aukland-Peck
, Ilya Balabanovsky
, Margaret Howard
, Chaim Lapp
, Hannah R. Levine
, Zoe Jacoby
, Kaitlyn McGill
-
2023 Private Equity Midyear Outlook
27 July 2023
Christopher Anthony
, Katherine Ashton
, Dominic Blaxill
, Ezra Borut
, Geoffrey P. Burgess
, Andrew J. Ceresney
, Jeffrey P. Cunard
, E. Drew Dutton
, Jane Engelhardt
, Andrew Ford
, Andrew J. Gershon
, Mark P. Goodman
, Jyotin Hamid
, Ted Hassi
, Morgan J. Hayes
, Emily F. Huang
, Peter J. Irwin
, Eric T. Juergens
, Robert B. Kaplan
, Rafael Kariyev
, Meir D. Katz
, M. Natasha Labovitz
, Maurizio Levi-Minzi
, Andrew M. Levine
, Sidney P. Levinson
, Jonathan F. Lewis
, Timothy McIver
, Frank Mitchell
, Maura Kathleen Monaghan
, Edwin Northover
, Brett M. Novick
, Marc Ponchione
, Julie M. Riewe
, Shannon Rose Selden
, Steven J. Slutzky
, Thomas Smith
, Kristin A. Snyder
, J. Michael Snypes, Jr.
, Patrick Taylor
, Ramya S. Tiller
, Patricia Volhard
, Richard Ward
, Erica S. Weisgerber
, Alison E. Buckley-Serfass
, Brett Adam Bush
, Zhiyan Cao
, Robert T. Dura
, Stuart Hammer
, Megan McGuiggan
, Sheena Paul
, Tricia Bozyk Sherno
, Ulysses Smith
, Jacob W. Stahl
, Sergio Torres
, Jennifer Wheater
, Elie J. Worenklein
, Adam Aukland-Peck
, Colleen B. Bernaiche
, Charles Cartiglia
, Paul Eastham
, Jay E. Evans
, Sara Ewad
, Christopher Gossage
, Camila Isern
, Yiran Ji
, Maryam Kanna
, Rekha Korlipara
, Adriana Kranjac
, Samuel D. Krawiecz
, Harshil Mehta
, Gianni Pizzitola
, Stanley G. Seckler
, Sheng Shao
, Massy Vainshtein
-
Sackett v. EPA: Supreme Court Clarifies Clean Water Act Scope but Creates Uncertainty for Companies and Investors
7 July 2023
Shannon Rose Selden
, Adam Aukland-Peck
, Ulysses Smith
-
Legal Dispute Surrounding Abortion Pill Has Significant Implications for Broader Healthcare Industry
9 May 2023
Andrew L. Bab
, Maura Kathleen Monaghan
, Paul D. Rubin
, Shannon Rose Selden
, Kim T. Le
, Jacob W. Stahl
, Adam Aukland-Peck
, Melissa Runsten
-
Reuters: The new frontier of fraud, waste and abuse: COVID-related misconduct enforcement trends
27 March 2023
Reuters
Maura Kathleen Monaghan
, Winston M. Paes
, Adam Aukland-Peck
, Hannah R. Levine
-
Top 15 Healthcare and Life Sciences Issues to Watch in 2023
9 January 2023
Andrew L. Bab
, Jennifer L. Chu
, Mark P. Goodman
, Maura Kathleen Monaghan
, Kevin Rinker
, Paul D. Rubin
, Michael Schaper
, Erica S. Weisgerber
, Kim T. Le
, Jacob W. Stahl
, Elie J. Worenklein
, Samuel J. Allaman
, Adam Aukland-Peck
, Hannah R. Levine
, Melissa Runsten
, Adam C. Saunders
, Adrian St. Francis
, Emily G. Dennan
, Micah A. Rubin
-
Recent SCOTUS Decisions Impacting Healthcare
3 August 2022
Andrew L. Bab
, Mark P. Goodman
, Maura Kathleen Monaghan
, Kevin Rinker
, Paul D. Rubin
, Kim T. Le
, Jacob W. Stahl
, Adam Aukland-Peck
-
Texas Federal Judge Sides with Providers in “No Surprises Act” Ruling
1 March 2022
Andrew L. Bab
, Jennifer L. Chu
, Mark P. Goodman
, Maura Kathleen Monaghan
, Kevin Rinker
, Paul D. Rubin
, Kim T. Le
, Jacob W. Stahl
, Adam Aukland-Peck
, Adriana Kranjac
, Hannah R. Levine
, Melissa Runsten
-
2021/2022 Private Equity Year-End Review and Outlook
January 2022
Jonathan Adler
, Catherine Amirfar
, Christopher Anthony
, Katherine Ashton
, Andrew L. Bab
, Geoffrey P. Burgess
, Ezra Borut
, Andrew J. Ceresney
, Jennifer L. Chu
, Jeffrey P. Cunard
, Alexander R. Cochran
, E. Drew Dutton
, Jane Engelhardt
, Morgan J. Hayes
, Eric T. Juergens
, Maurizio Levi-Minzi
, Nicholas P. Pellicani
, Ryan T. Rafferty
, Julie M. Riewe
, Scott B. Selinger
, Marc Ponchione
, Thomas Smith
, Ramya S. Tiller
, Patricia Volhard
, Richard Ward
, Marshal L. Bozzo
, Christopher Dortschy
, Andrew J. Gershon
, Emily F. Huang
, Jennifer Wheater
, Dominic Blaxill
, Charles Cartiglia
, Robert T. Dura
, Matthew J. Sacco
, Sheng Shao
, Sergio Torres
, Charlotte A. Walkovik
, Paul Eastham
, Christopher Gossage
, Robert B. Kaplan
, Sheena Paul
, John Young
, Jin-Hyuk Jang
, Lukas Ott
, Andrew M. Levine
, Stuart Hammer
, Ulysses Smith
, Luke Dembosky
, Avi Gesser
, Peter J. Irwin
, Ina C. Popova
, Samantha J. Rowe
, M. Natasha Labovitz
, Sidney P. Levinson
, Paul D. Rubin
, Eric Dinallo
, Marilyn A. Lion
, Jacob W. Stahl
, Nicholas F. Potter
, Kim T. Le
, Adam Aukland-Peck
, Melissa Runsten
, Matthew Mrozek
, Michael C. Godbe
, Christel Y. Tham
, Lisa Wang Lachowicz
, Yiran Ji
-
Law360: Medicare Advantage Plans Must Beware DOJ Scrutiny
5 January 2022
Law360
Winston M. Paes
, Kristin D. Kiehn
, Adam Aukland-Peck
-
2021 Private Equity Midyear Review and Outlook
22 July 2021
Jonathan Adler
, Christopher Anthony
, Katherine Ashton
, Andrew L. Bab
, Megan K. Bannigan
, Sally Bergmann Hardesty
, David H. Bernstein
, Paul S. Bird
, Ezra Borut
, Geoffrey P. Burgess
, Jennifer L. Chu
, Matthew Dickman
, Christopher Dortschy
, E. Drew Dutton
, Jane Engelhardt
, Peter A. Furci
, Avi Gesser
, Jyotin Hamid
, Morgan J. Hayes
, Peter J. Irwin
, Meir D. Katz
, Rafael Kariyev
, M. Natasha Labovitz
, Maurizio Levi-Minzi
, Andrew M. Levine
, Sidney P. Levinson
, Jonathan F. Lewis
, Marc Ponchione
, Ryan T. Rafferty
, Paul D. Rubin
, Zachary H. Saltzman
, Kevin M. Schmidt
, Shannon Rose Selden
, Scott B. Selinger
, Steven J. Slutzky
, Ramya S. Tiller
, Richard Ward
, Patricia Volhard
, Franci J. Blassberg
, Jeffrey P. Cunard
, Andrew J. Gershon
, Stuart Hammer
, Jin-Hyuk Jang
, Kim T. Le
, Sheena Paul
, Tricia Bozyk Sherno
, Jacob W. Stahl
, Jennifer Wheater
, John Young
, Adam Aukland-Peck
, Dominic Blaxill
, Charles Cartiglia
, Robert T. Dura
, Paul Eastham
, Jay E. Evans
, David J. Hotelling
, Samuel D. Krawiecz
, Wen-Wei Lai
, Robert Maddox
, Sergio Torres
, Malina Welman
-
The Supreme Court TransUnion Case: Part 2—What It Means for Efforts to Defeat Class Certification?
9 July 2021
Mark P. Goodman
, Maura Kathleen Monaghan
, Jim Pastore
, Jacob W. Stahl
, Adam Aukland-Peck
, Benjamin Leb
-
Law360: TCPA Litigation And Compliance After Facebook Ruling
13 April 2021
Law360
Maura Kathleen Monaghan
, Jacob W. Stahl
, Adam Aukland-Peck
-
The Supreme Court Rules for Facebook: What It Means for TCPA Compliance and Class Certification Defense
7 April 2021
Courtney M. Dankworth
, Maura Kathleen Monaghan
, Jacob W. Stahl
, Adam Aukland-Peck
-
The Eleventh Circuit Precludes “Administrative Feasibility” but Provides a Path Forward for Defendants Opposing Class Certification in Consumer Class Actions
9 February 2021
Maura Kathleen Monaghan
, Kristin D. Kiehn
, Jacob W. Stahl
, Adam Aukland-Peck
View More Publications